CircLIFR suppresses hepatocellular carcinoma progression by sponging miR-624-5p and inactivating the GSK-3β/β-catenin signaling pathway.
- Resource Type
- Article
- Source
- Cell Death & Disease; May2022, Vol. 13 Issue 5, p1-11, 11p
- Subject
- Language
- ISSN
- 20414889